Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.84 is in line with its 5-year average of -2.01, around the middle of its 5-year range (-5.37–0.14).
121.17% below its 12-month average of -0.83.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.53.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 25 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:37:03.628Z. Historical observations retain their original dates. Historical series through 2025-05-13.
EARNINGS PER SHARE (EPS)
-1.84
EARNINGS PER SHARE (EPS) AVG TTM
-0.83
EARNINGS PER SHARE (EPS) AVG 3Y
-0.99
EARNINGS PER SHARE (EPS) AVG 5Y
-2.01
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-121.17%
CURRENT VS 3Y AVG
-86.09%
CURRENT VS 5Y AVG
+8.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Immatics N.V.
Market Cap
$1.01B
Earnings Per Share (EPS)
-1.84
TTM Avg
-0.83
3Y Avg
-0.99
5Y Avg
-2.01
Market Cap
$1.00B
Earnings Per Share (EPS)
-3.37
TTM Avg
-3.42
3Y Avg
-2.02
5Y Avg
-1.79
Market Cap
$1.02B
Earnings Per Share (EPS)
-0.38
TTM Avg
-0.83
3Y Avg
-0.98
5Y Avg
-0.98
Market Cap
$1.02B
Earnings Per Share (EPS)
-1.64
TTM Avg
-1.56
3Y Avg
-1.49
5Y Avg
-1.15
Market Cap
$994.58M
Earnings Per Share (EPS)
N/A
TTM Avg
-52.25
3Y Avg
-46.52
5Y Avg
-41.75
Market Cap
$1.01B
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.08
3Y Avg
-1.22
5Y Avg
-1.11
Market Cap
$1.02B
Earnings Per Share (EPS)
-0.09
TTM Avg
-3.41
3Y Avg
-0.94
5Y Avg
-0.03
Market Cap
$988.10M
Earnings Per Share (EPS)
-1.94
TTM Avg
-1.73
3Y Avg
-1.92
5Y Avg
-1.76
Market Cap
$986.21M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immatics N.V. (IMTX) | $1.01B | -1.84 | -0.83 | -0.99 | -2.01 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.00B | -3.37 | -3.42 | -2.02 | -1.79 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | -0.38 | -0.83 | -0.98 | -0.98 |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | -1.64 | -1.56 | -1.49 | -1.15 |
| Vor Biopharma Inc. (VOR)vs › | $994.58M | N/A | -52.25 | -46.52 | -41.75 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.01B | -0.66 | -0.08 | -1.22 | -1.11 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.02B | -0.09 | -3.41 | -0.94 | -0.03 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $988.10M | -1.94 | -1.73 | -1.92 | -1.76 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $986.21M | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $981.32M | -2.97 | -9.41 | -6.16 | -6.16 |
Trailing EPS (TTM)
$-1.84
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.81 |
| 2024-12-31 | 0.14 |
| 2023-12-31 | -1.30 |
| 2021-12-31 | -1.68 |
| 2020-12-31 | -5.37 |
| 2019-12-31 | -0.56 |
| 2018-12-31 | -0.57 |
